{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:15:58Z","timestamp":1792696558676,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000104","name":"NASA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005349","name":"American Association of Colleges of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006940","name":"University of Mississippi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jbc.2021.101207","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T01:15:27Z","timestamp":1631841327000},"page":"101207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection"],"prefix":"10.1016","volume":"297","author":[{"given":"Rohini","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kucheryavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-5244","authenticated-orcid":false,"given":"AyoOluwa O.","family":"Aderibigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2219-5833","authenticated-orcid":false,"given":"Robert J.","family":"Linhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3789-1842","authenticated-orcid":false,"given":"Robert J.","family":"Doerksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor H.","family":"Pomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.101207_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2021.101207_bib2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: Current state of the Science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2021.101207_bib3","doi-asserted-by":"crossref","first-page":"173926","DOI":"10.1016\/j.ejphar.2021.173926","article-title":"Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis","volume":"897","author":"Rezagholizadeh","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2021.101207_bib4","doi-asserted-by":"crossref","first-page":"220384","DOI":"10.1183\/16000617.0384-2020","article-title":"Current evidence for COVID-19 therapies: A systematic literature review","volume":"30","author":"Welte","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jbc.2021.101207_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: A comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jbc.2021.101207_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101207_bib7","doi-asserted-by":"crossref","first-page":"628551","DOI":"10.3389\/fmolb.2020.628551","article-title":"Elucidating the interactions between heparin\/heparan sulfate and SARS-CoV-2-related proteins\u2014an important strategy for developing novel therapeutics for the COVID-19 pandemic","volume":"7","author":"Yu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jbc.2021.101207_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v11070596","article-title":"Heparan sulfate proteoglycans and viral attachment: True receptors or adaptation bias?","volume":"11","author":"Cagno","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jbc.2021.101207_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/viro.2002.1484","article-title":"Role of heparan sulfate in human parainfluenza virus type 3 infection","volume":"298","author":"Bose","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jbc.2021.101207_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/viro.1999.0171","article-title":"Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions","volume":"268","author":"Dechecchi","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.jbc.2021.101207_bib11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101207_bib12","doi-asserted-by":"crossref","first-page":"105077","DOI":"10.1016\/j.antiviral.2021.105077","article-title":"Antiviral activities of four sulfated marine glycans against adenovirus and human cytomegalovirus","volume":"190","author":"Zoepfl","year":"2021","journal-title":"Antivir. Res"},{"key":"10.1016\/j.jbc.2021.101207_bib13","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1074\/jbc.M006701200","article-title":"Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans","volume":"276","author":"Tyagi","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib14","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.1074\/jbc.M500911200","article-title":"Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site","volume":"280","author":"Viv\u00e8s","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.jbc.2021.101207_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI200113799","article-title":"Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry","volume":"108","author":"Shukla","year":"2001","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jbc.2021.101207_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.jbc.2021.101207_bib18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2021.101207_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61390","article-title":"ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities","volume":"9","author":"Zamorano Cuervo","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2021.101207_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101207_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101207_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.101207_bib23","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S1473-3099(21)00007-4","article-title":"First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020","volume":"21","author":"Fiorentini","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbc.2021.101207_bib24","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/1873-3468.14076","article-title":"Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: Insights from molecular dynamics simulations","volume":"595","author":"Luan","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2021.101207_bib25","article-title":"The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation","author":"Santos","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2021.101207_bib26","article-title":"Early analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein","author":"Golubchik","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jbc.2021.101207_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01987-20","article-title":"Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives","volume":"95","author":"Tandon","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.101207_bib28","doi-asserted-by":"crossref","first-page":"104873","DOI":"10.1016\/j.antiviral.2020.104873","article-title":"Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions","volume":"181","author":"Kim","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.jbc.2021.101207_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijbiomac.2021.04.148","article-title":"Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy","volume":"183","author":"Gupta","year":"2021","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.jbc.2021.101207_bib30","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1055\/s-0040-1721319","article-title":"Heparin inhibits cellular invasion by SARS-CoV-2: Structural dependence of the interaction of the spike S1 receptor-binding domain with heparin","volume":"120","author":"Mycroft-West","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbc.2021.101207_bib31","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy: Heparin","volume":"103","author":"Hirsh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2021.101207_bib32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.101207_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0049-3848(82)90006-8","article-title":"Comparison of the in\u00a0vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction","volume":"27","author":"Ockelford","year":"1982","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jbc.2021.101207_bib34","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.csbj.2021.05.002","article-title":"Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain","volume":"19","author":"Schuurs","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jbc.2021.101207_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/md16070233","article-title":"Marine carbohydrate-based compounds with medicinal properties","volume":"16","author":"Vasconcelos","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/microorganisms5030051","article-title":"The sea as a rich source of structurally unique glycosaminoglycans and mimetics","volume":"5","author":"Vasconcelos","year":"2017","journal-title":"Microorganisms"},{"key":"10.1016\/j.jbc.2021.101207_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ph11010027","article-title":"Glycosaminoglycans and proteoglycans","volume":"11","author":"Pomin","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jbc.2021.101207_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bbagen.2012.08.022","article-title":"Fucanomics and galactanomics: Current status in drug discovery, mechanisms of action and role of the well-defined structures","volume":"1820","author":"Pomin","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2021.101207_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/glycob\/cwn085","article-title":"Structure, biology, evolution, and medical importance of sulfated fucans and galactans","volume":"18","author":"Pomin","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2021.101207_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/ph8040848","article-title":"Marine non-glycosaminoglycan sulfated glycans as potential pharmaceuticals","volume":"8","author":"Pomin","year":"2015","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jbc.2021.101207_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1568026615666150605104444","article-title":"Antimicrobial sulfated glycans: Structure and function","volume":"17","author":"Pomin","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.carbpol.2012.07.026","article-title":"Anticancer polysaccharides from natural resources: A review of recent research","volume":"90","author":"Zong","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib43","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/md13052770","article-title":"Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs","volume":"13","author":"Mour\u00e3o","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ijbiomac.2020.09.184","article-title":"The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica","volume":"163","author":"Jin","year":"2020","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.jbc.2021.101207_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/md19040219","article-title":"Inhibition of SARS-CoV-2 virus entry by the crude polysaccharides of seaweeds and abalone viscera in\u00a0vitro","volume":"19","author":"Yim","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-020-00192-8","article-title":"Sulfated polysaccharides effectively inhibit SARS-CoV-2 in\u00a0vitro","volume":"6","author":"Kwon","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.jbc.2021.101207_bib47","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1039\/D0FO02017F","article-title":"Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.jbc.2021.101207_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/md12010232","article-title":"Holothurian fucosylated chondroitin sulfate","volume":"12","author":"Pomin","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib49","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/glycob\/cwy048","article-title":"A\u00a0unique fucosylated chondroitin sulfate type II with strikingly homogeneous and neatly distributed \u03b1-fucose branches","volume":"28","author":"Soares","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2021.101207_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbagen.2012.03.002","article-title":"Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus","volume":"1820","author":"Chen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2021.101207_bib51","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.carbpol.2010.08.040","article-title":"Comparison of structures and anticoagulant activities of fucosylated chondroitin sulfates from different sea cucumbers","volume":"83","author":"Chen","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.carres.2015.05.004","article-title":"NMR structural determination of unique invertebrate glycosaminoglycans endowed with medical properties","volume":"413","author":"Pomin","year":"2015","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jbc.2021.101207_bib53","doi-asserted-by":"crossref","first-page":"29299","DOI":"10.1074\/jbc.M002422200","article-title":"Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates","volume":"275","author":"Farias","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib54","doi-asserted-by":"crossref","first-page":"107407","DOI":"10.1016\/j.jsb.2019.107407","article-title":"Conformational properties of l-fucose and the tetrasaccharide building block of the sulfated l-fucan from Lytechinus variegatus","volume":"209","author":"Bezerra","year":"2020","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.jbc.2021.101207_bib55","series-title":"GLYCAM Web","year":"2005"},{"key":"10.1016\/j.jbc.2021.101207_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00001721-200009000-00009","article-title":"Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm","volume":"11","author":"Pacheco","year":"2000","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jbc.2021.101207_bib57","doi-asserted-by":"crossref","first-page":"23973","DOI":"10.1074\/jbc.271.39.23973","article-title":"Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action","volume":"271","author":"Mour\u00e3o","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2018.05.024","article-title":"Modulating the degree of fucosylation of fucosylated chondroitin sulfate enhances heparin cofactor II-dependent thrombin inhibition","volume":"154","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.sbi.2017.10.011","article-title":"Unveiling the structure of sulfated fucose-rich polysaccharides via nuclear magnetic resonance spectroscopy","volume":"50","author":"Mour\u00e3o","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jbc.2021.101207_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/md18110540","article-title":"Fucosylated chondroitin sulfates from the sea cucumbers paracaudina chilensis and Holothuria hilla: Structures and anticoagulant activity","volume":"18","author":"Ustyuzhanina","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.carbpol.2017.01.034","article-title":"Two fucosylated chondroitin sulfates from the sea cucumber Eupentacta fraudatrix","volume":"164","author":"Ustyuzhanina","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib62","doi-asserted-by":"crossref","first-page":"117969","DOI":"10.1016\/j.carbpol.2021.117969","article-title":"Structural elucidation and antidiabetic activity of fucosylated chondroitin sulfate from sea cucumber Stichopus japonicas","volume":"262","author":"Gong","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10719-014-9530-1","article-title":"Anticoagulant motifs of marine sulfated glycans","volume":"31","author":"Pomin","year":"2014","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jbc.2021.101207_bib64","first-page":"33","article-title":"Specific sulfation and glycosylation\u2014a structural combination for the anticoagulation of marine carbohydrates","volume":"34","author":"Pomin","year":"2014","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2021.101207_bib65","article-title":"Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2","author":"Liu","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2021.101207_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.scib.2021.01.010","article-title":"Binding of the SARS-CoV-2 spike protein to glycans","author":"Hao","year":"2021","journal-title":"Sci. Bull"},{"key":"10.1016\/j.jbc.2021.101207_bib67","article-title":"Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3-O-sulfated heparan sulfate","author":"Tiwari","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2021.101207_bib68","article-title":"SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2021.101207_bib69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/glycob\/cwi021","article-title":"Selective cleavage and anticoagulant activity of a sulfated fucan: Stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis , preparation of oligosaccharides , and heparin cofactor II \u2013 dependent anticoagulant activity","volume":"15","author":"Pomin","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.jbc.2021.101207_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1160\/TH07-10-0649","article-title":"An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases","volume":"99","author":"Melo","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbc.2021.101207_bib71","doi-asserted-by":"crossref","first-page":"20824","DOI":"10.1074\/jbc.M308688200","article-title":"Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: Different mechanisms for heparin and sulfated galactans","volume":"279","author":"Melo","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib72","doi-asserted-by":"crossref","first-page":"28284","DOI":"10.1074\/jbc.M114.572297","article-title":"Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali","volume":"289","author":"Panagos","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib73","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jbc.2021.101207_bib74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neo.2017.11.011","article-title":"A\u00a0heparin binding motif rich in arginine and lysine is the functional domain of YKL-40","volume":"20","author":"Ngernyuang","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2021.101207_bib75","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/molecules24152803","article-title":"Galactosaminoglycans: Medical applications and drawbacks","volume":"24","author":"Pomin","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2021.101207_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.2007.059188","article-title":"Heparin induced thrombocytopenia: Diagnosis and management update","volume":"83","author":"Ahmed","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jbc.2021.101207_bib77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/md10040793","article-title":"Fucanomics and galactanomics: Marine distribution, medicinal impact, conceptions, and challenges","volume":"10","author":"Pomin","year":"2012","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.07.065","article-title":"Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size","volume":"139","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib79","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1160\/TH08-11-0773","article-title":"Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications","volume":"102","author":"Fonseca","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbc.2021.101207_bib80","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.bbagen.2013.01.001","article-title":"Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates","volume":"1830","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2021.101207_bib81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/03008208209160269","article-title":"A\u00a0direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures","volume":"9","author":"Farndale","year":"1982","journal-title":"Connect Tissue Res."},{"key":"10.1016\/j.jbc.2021.101207_bib82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0144-8617(03)00144-9","article-title":"A\u00a096-well assay for uronic acid carbazole reaction","volume":"54","author":"Cesaretti","year":"2003","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib84","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.biomaterials.2005.08.003","article-title":"Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves","volume":"27","author":"Lovekamp","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbc.2021.101207_bib85","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/md16090304","article-title":"Anticoagulant and antithrombotic properties of three structurally correlated sea urchin sulfated glycans and their low-molecular-weight derivatives","volume":"16","author":"Vasconcelos","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jbc.2021.101207_bib86","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/s41598-020-76135-w","article-title":"Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein","volume":"10","author":"Tandon","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2021.101207_bib87","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/acs.jpclett.0c03570","article-title":"Aptamer conjugated gold nanostar-based distance-dependent nanoparticle surface energy transfer spectroscopy for ultrasensitive detection and inactivation of corona virus","volume":"12","author":"Pramanik","year":"2021","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.jbc.2021.101207_bib88","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1039\/D0NA01007C","article-title":"The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles","volume":"3","author":"Pramanik","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jbc.2021.101207_bib89","doi-asserted-by":"crossref","first-page":"117797","DOI":"10.1016\/j.carbpol.2021.117797","article-title":"Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus","volume":"260","author":"Yan","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib90","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1002\/jps.22527","article-title":"Impact of autoclave sterilization on the activity and structure of formulated heparin","volume":"100","author":"Beaudet","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.jbc.2021.101207_bib91","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jcc.20820","article-title":"GLYCAM06: A generalizable biomolecular force field. Carbohydrates","volume":"29","author":"Kirschner","year":"2008","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib92","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.jbc.2021.101207_bib93","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jbc.2021.101207_bib94","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/ja00119a045","article-title":"Molecular dynamics simulations on solvated biomolecular systems: The particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins","volume":"117","author":"Cheatham","year":"1995","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2021.101207_bib95","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jbc.2021.101207_bib96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J.\u00a0Mol. Graph"},{"key":"10.1016\/j.jbc.2021.101207_bib97","unstructured":"The PyMOL Molecular Graphics System, Version 2.0, Schrodinger, LLC, New York, NY."},{"key":"10.1016\/j.jbc.2021.101207_bib98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib99","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jbc.2021.101207_bib100","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/S0040-4039(01)94977-9","article-title":"A\u00a0new model for calculating atomic charges in molecules","volume":"19","author":"Gasteiger","year":"1978","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jbc.2021.101207_bib101","doi-asserted-by":"crossref","first-page":"115698","DOI":"10.1016\/j.carbpol.2019.115698","article-title":"Two different fucosylated chondroitin sulfates: Structural elucidation, stimulating hematopoiesis and immune-enhancing effects","volume":"230","author":"Niu","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jbc.2021.101207_bib102","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/glycob\/cws055","article-title":"Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides","volume":"22","author":"Pomin","year":"2012","journal-title":"Glycobiology"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821010097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821010097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:12:11Z","timestamp":1758240731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821010097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0021925821010097"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101207","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.101207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101207"}}